averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
KLF8
|
ENSG00000102349.10 | Kruppel like factor 8 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
KLF8 | hg19_v2_chrX_+_56259316_56259480 | 0.57 | 6.4e-20 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_222846 | 53.06 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr6_+_31865552 | 38.14 |
ENST00000469372.1
ENST00000497706.1 |
C2
|
complement component 2 |
chr21_-_46330545 | 36.81 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr19_-_17185848 | 34.86 |
ENST00000593360.1
|
HAUS8
|
HAUS augmin-like complex, subunit 8 |
chr1_+_6845384 | 34.09 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
chr16_+_226658 | 30.94 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr3_+_10206545 | 27.40 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
chr6_-_33048483 | 27.18 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr15_+_69222827 | 27.07 |
ENST00000310673.3
ENST00000448182.3 ENST00000260364.5 |
SPESP1
NOX5
|
sperm equatorial segment protein 1 NADPH oxidase, EF-hand calcium binding domain 5 |
chr17_-_42277203 | 26.83 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr1_-_38157877 | 26.55 |
ENST00000477060.1
ENST00000491981.1 ENST00000488137.1 |
C1orf109
|
chromosome 1 open reading frame 109 |
chr3_+_40566369 | 26.53 |
ENST00000403205.2
ENST00000310898.1 ENST00000339296.5 ENST00000431278.1 |
ZNF621
|
zinc finger protein 621 |
chr12_+_50355647 | 26.23 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
chr14_-_106209368 | 24.37 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr22_+_22712087 | 24.03 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr8_-_27468842 | 23.48 |
ENST00000523500.1
|
CLU
|
clusterin |
chr15_+_69222909 | 22.48 |
ENST00000455873.3
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5 |
chr3_-_58572760 | 22.42 |
ENST00000447756.2
|
FAM107A
|
family with sequence similarity 107, member A |
chr11_-_64512469 | 22.05 |
ENST00000377485.1
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr19_+_16435625 | 21.76 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr3_-_126194707 | 21.68 |
ENST00000336332.5
ENST00000389709.3 |
ZXDC
|
ZXD family zinc finger C |
chr1_-_182360498 | 21.03 |
ENST00000417584.2
|
GLUL
|
glutamate-ammonia ligase |
chr9_+_139871948 | 20.97 |
ENST00000224167.2
ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr9_+_139874683 | 20.84 |
ENST00000444903.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr20_+_30640004 | 20.79 |
ENST00000520553.1
ENST00000518730.1 ENST00000375852.2 |
HCK
|
hemopoietic cell kinase |
chr17_-_41465674 | 20.55 |
ENST00000592135.1
ENST00000587874.1 ENST00000588654.1 ENST00000592094.1 |
LINC00910
|
long intergenic non-protein coding RNA 910 |
chr8_-_27468945 | 20.37 |
ENST00000405140.3
|
CLU
|
clusterin |
chr18_-_74701962 | 20.18 |
ENST00000585201.1
|
MBP
|
myelin basic protein |
chr5_-_139944196 | 19.85 |
ENST00000357560.4
|
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr19_+_56915668 | 19.61 |
ENST00000333201.9
ENST00000391778.3 |
ZNF583
|
zinc finger protein 583 |
chr19_+_35630022 | 19.28 |
ENST00000589209.1
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr11_-_64512273 | 19.27 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr20_+_30639991 | 19.17 |
ENST00000534862.1
ENST00000538448.1 ENST00000375862.2 |
HCK
|
hemopoietic cell kinase |
chr19_+_2977444 | 19.09 |
ENST00000246112.4
ENST00000453329.1 ENST00000482627.1 ENST00000452088.1 |
TLE6
|
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) |
chr6_+_33048222 | 19.07 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr22_+_45898712 | 18.81 |
ENST00000455233.1
ENST00000348697.2 ENST00000402984.3 ENST00000262722.7 ENST00000327858.6 ENST00000442170.2 ENST00000340923.5 ENST00000439835.1 |
FBLN1
|
fibulin 1 |
chr18_-_74728998 | 18.81 |
ENST00000359645.3
ENST00000397875.3 ENST00000397869.3 ENST00000578193.1 ENST00000578873.1 ENST00000397866.4 ENST00000528160.1 ENST00000527041.1 ENST00000526111.1 ENST00000397865.5 ENST00000382582.3 |
MBP
|
myelin basic protein |
chr19_+_35629702 | 18.77 |
ENST00000351325.4
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr22_+_22681656 | 18.61 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr2_+_95691445 | 18.41 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
chr22_+_23248512 | 18.40 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
chr19_+_45409011 | 18.37 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
chr17_+_1665345 | 18.36 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr8_-_27457494 | 18.26 |
ENST00000521770.1
|
CLU
|
clusterin |
chr6_-_170101749 | 18.25 |
ENST00000448612.1
|
WDR27
|
WD repeat domain 27 |
chr14_-_106092403 | 18.13 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr19_+_57831829 | 18.09 |
ENST00000321545.4
|
ZNF543
|
zinc finger protein 543 |
chr11_-_117747607 | 17.90 |
ENST00000540359.1
ENST00000539526.1 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr6_-_32557610 | 17.90 |
ENST00000360004.5
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1 |
chr2_+_95691417 | 17.86 |
ENST00000309988.4
|
MAL
|
mal, T-cell differentiation protein |
chr19_+_5623186 | 17.82 |
ENST00000538656.1
|
SAFB
|
scaffold attachment factor B |
chr17_+_38083977 | 17.61 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
chr1_+_1510337 | 16.84 |
ENST00000366221.2
|
AL645728.1
|
Uncharacterized protein |
chr6_+_42847348 | 16.64 |
ENST00000493763.1
ENST00000304734.5 |
RPL7L1
|
ribosomal protein L7-like 1 |
chr20_-_4804244 | 16.46 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr9_+_139873264 | 16.43 |
ENST00000446677.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr2_+_90139056 | 16.28 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr14_+_102027688 | 16.27 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
chr10_-_105452917 | 16.20 |
ENST00000427662.2
|
SH3PXD2A
|
SH3 and PX domains 2A |
chr2_-_89310012 | 16.20 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr1_-_11866034 | 15.70 |
ENST00000376590.3
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr19_+_53836985 | 15.43 |
ENST00000601857.1
ENST00000595091.1 ENST00000458035.1 |
ZNF845
|
zinc finger protein 845 |
chr3_-_57678772 | 15.42 |
ENST00000311128.5
|
DENND6A
|
DENN/MADD domain containing 6A |
chr12_+_4918342 | 15.38 |
ENST00000280684.3
ENST00000433855.1 |
KCNA6
|
potassium voltage-gated channel, shaker-related subfamily, member 6 |
chr19_-_33793430 | 15.36 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
chr1_-_182361327 | 15.30 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
chr22_+_22786288 | 15.15 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr16_+_84178874 | 15.05 |
ENST00000378553.5
|
DNAAF1
|
dynein, axonemal, assembly factor 1 |
chr1_-_31230650 | 15.00 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
chr8_+_24772455 | 14.81 |
ENST00000433454.2
|
NEFM
|
neurofilament, medium polypeptide |
chr19_+_7069426 | 14.70 |
ENST00000252840.6
ENST00000414706.1 |
ZNF557
|
zinc finger protein 557 |
chr14_-_81687197 | 14.55 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr11_-_117748138 | 14.46 |
ENST00000527717.1
|
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr1_+_151254738 | 14.30 |
ENST00000336715.6
ENST00000324048.5 ENST00000368879.2 |
ZNF687
|
zinc finger protein 687 |
chr22_+_22735135 | 14.24 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr19_-_11591848 | 14.16 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
chr14_+_57857262 | 14.15 |
ENST00000555166.1
ENST00000556492.1 ENST00000554703.1 |
NAA30
|
N(alpha)-acetyltransferase 30, NatC catalytic subunit |
chr7_-_35734730 | 14.14 |
ENST00000396081.1
ENST00000311350.3 |
HERPUD2
|
HERPUD family member 2 |
chr15_+_90777424 | 14.12 |
ENST00000561433.1
ENST00000559204.1 ENST00000558291.1 |
GDPGP1
|
GDP-D-glucose phosphorylase 1 |
chr14_+_73704201 | 14.05 |
ENST00000340738.5
ENST00000427855.1 ENST00000381166.3 |
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein |
chr1_+_26644441 | 14.02 |
ENST00000374213.2
|
CD52
|
CD52 molecule |
chr11_+_117049445 | 14.00 |
ENST00000324225.4
ENST00000532960.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
chr19_-_49945617 | 13.85 |
ENST00000600601.1
ENST00000543531.1 |
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
chr3_-_167813672 | 13.85 |
ENST00000470487.1
|
GOLIM4
|
golgi integral membrane protein 4 |
chr21_-_46348694 | 13.83 |
ENST00000355153.4
ENST00000397850.2 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr21_+_47878757 | 13.81 |
ENST00000400274.1
ENST00000427143.2 ENST00000318711.7 ENST00000457905.3 ENST00000466639.1 ENST00000435722.3 ENST00000417564.2 |
DIP2A
|
DIP2 disco-interacting protein 2 homolog A (Drosophila) |
chr19_+_50706866 | 13.81 |
ENST00000440075.2
ENST00000376970.2 ENST00000425460.1 ENST00000599920.1 ENST00000601313.1 |
MYH14
|
myosin, heavy chain 14, non-muscle |
chr11_+_62439126 | 13.80 |
ENST00000377953.3
|
C11orf83
|
chromosome 11 open reading frame 83 |
chr17_-_5138099 | 13.73 |
ENST00000571800.1
ENST00000574081.1 ENST00000399600.4 ENST00000574297.1 |
SCIMP
|
SLP adaptor and CSK interacting membrane protein |
chr22_-_19974616 | 13.59 |
ENST00000344269.3
ENST00000401994.1 ENST00000406522.1 |
ARVCF
|
armadillo repeat gene deleted in velocardiofacial syndrome |
chr1_+_1260147 | 13.58 |
ENST00000343938.4
|
GLTPD1
|
glycolipid transfer protein domain containing 1 |
chr14_-_106054659 | 13.51 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr9_-_86571628 | 13.48 |
ENST00000376344.3
|
C9orf64
|
chromosome 9 open reading frame 64 |
chr20_+_1206679 | 13.46 |
ENST00000402452.1
ENST00000409241.1 ENST00000381882.2 ENST00000246108.3 |
RAD21L1
|
RAD21-like 1 (S. pombe) |
chr11_-_125366089 | 13.45 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
chr16_+_58283814 | 13.39 |
ENST00000443128.2
ENST00000219299.4 |
CCDC113
|
coiled-coil domain containing 113 |
chr22_+_39745930 | 13.32 |
ENST00000318801.4
ENST00000216155.7 ENST00000406293.3 ENST00000328933.5 |
SYNGR1
|
synaptogyrin 1 |
chr17_+_1665253 | 13.26 |
ENST00000254722.4
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr16_-_1843720 | 13.23 |
ENST00000415638.3
ENST00000215539.3 |
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit |
chr13_-_44453826 | 13.19 |
ENST00000444614.3
|
CCDC122
|
coiled-coil domain containing 122 |
chrX_+_16737718 | 13.19 |
ENST00000380155.3
|
SYAP1
|
synapse associated protein 1 |
chr6_-_84419101 | 13.18 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr11_-_64511789 | 13.12 |
ENST00000419843.1
ENST00000394430.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr8_+_95908041 | 13.11 |
ENST00000396113.1
ENST00000519136.1 |
NDUFAF6
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 |
chr11_-_72385437 | 13.09 |
ENST00000418754.2
ENST00000542969.2 ENST00000334456.5 |
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated |
chr6_-_152957944 | 13.07 |
ENST00000423061.1
|
SYNE1
|
spectrin repeat containing, nuclear envelope 1 |
chrX_-_17878827 | 13.05 |
ENST00000360011.1
|
RAI2
|
retinoic acid induced 2 |
chr20_-_35492048 | 13.04 |
ENST00000237536.4
|
SOGA1
|
suppressor of glucose, autophagy associated 1 |
chr11_+_1891380 | 12.99 |
ENST00000429923.1
ENST00000418975.1 ENST00000406638.2 |
LSP1
|
lymphocyte-specific protein 1 |
chr3_+_153839149 | 12.96 |
ENST00000465093.1
ENST00000465817.1 |
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
chr22_+_47158518 | 12.86 |
ENST00000337137.4
ENST00000380995.1 ENST00000407381.3 |
TBC1D22A
|
TBC1 domain family, member 22A |
chr3_-_58613323 | 12.86 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
chr4_+_4388805 | 12.86 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
chr14_-_106330072 | 12.81 |
ENST00000488476.1
|
IGHJ5
|
immunoglobulin heavy joining 5 |
chrX_+_153524024 | 12.81 |
ENST00000369915.3
ENST00000217905.7 |
TKTL1
|
transketolase-like 1 |
chr19_-_54726850 | 12.78 |
ENST00000245620.9
ENST00000346401.6 ENST00000424807.1 ENST00000445347.1 |
LILRB3
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 |
chr14_-_81687575 | 12.77 |
ENST00000434192.2
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr11_-_61129335 | 12.72 |
ENST00000545361.1
ENST00000539128.1 ENST00000546151.1 ENST00000447532.2 |
CYB561A3
|
cytochrome b561 family, member A3 |
chr11_-_113746212 | 12.70 |
ENST00000537642.1
ENST00000537706.1 ENST00000544750.1 ENST00000260188.5 ENST00000540925.1 |
USP28
|
ubiquitin specific peptidase 28 |
chr3_+_45071622 | 12.62 |
ENST00000428034.1
|
CLEC3B
|
C-type lectin domain family 3, member B |
chr1_+_156698234 | 12.61 |
ENST00000368218.4
ENST00000368216.4 |
RRNAD1
|
ribosomal RNA adenine dimethylase domain containing 1 |
chr22_-_39548627 | 12.57 |
ENST00000216133.5
|
CBX7
|
chromobox homolog 7 |
chr5_+_150400124 | 12.53 |
ENST00000388825.4
ENST00000521650.1 ENST00000517973.1 |
GPX3
|
glutathione peroxidase 3 (plasma) |
chr19_+_5681011 | 12.48 |
ENST00000581893.1
ENST00000411793.2 ENST00000301382.4 ENST00000581773.1 ENST00000423665.2 ENST00000583928.1 ENST00000342970.2 ENST00000422535.2 ENST00000581521.1 ENST00000339423.2 |
HSD11B1L
|
hydroxysteroid (11-beta) dehydrogenase 1-like |
chrX_-_2418596 | 12.48 |
ENST00000381218.3
|
ZBED1
|
zinc finger, BED-type containing 1 |
chr14_-_100070363 | 12.40 |
ENST00000380243.4
|
CCDC85C
|
coiled-coil domain containing 85C |
chr22_+_23040274 | 12.39 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr17_-_76778339 | 12.35 |
ENST00000591455.1
ENST00000446868.3 ENST00000361101.4 ENST00000589296.1 |
CYTH1
|
cytohesin 1 |
chr7_-_139876812 | 12.33 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
chr14_-_106174960 | 12.31 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr1_+_233086326 | 12.30 |
ENST00000366628.5
ENST00000366627.4 |
NTPCR
|
nucleoside-triphosphatase, cancer-related |
chr22_+_23237555 | 12.29 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
chr14_-_21493884 | 12.28 |
ENST00000556974.1
ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2
|
NDRG family member 2 |
chr19_+_7069690 | 12.27 |
ENST00000439035.2
|
ZNF557
|
zinc finger protein 557 |
chr16_+_4784458 | 12.21 |
ENST00000590191.1
|
C16orf71
|
chromosome 16 open reading frame 71 |
chr1_-_11865982 | 12.20 |
ENST00000418034.1
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr11_-_117747434 | 12.13 |
ENST00000529335.2
ENST00000530956.1 ENST00000260282.4 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr17_-_617949 | 12.10 |
ENST00000401468.3
ENST00000574029.1 ENST00000291074.5 ENST00000571805.1 ENST00000437048.2 ENST00000446250.2 |
VPS53
|
vacuolar protein sorting 53 homolog (S. cerevisiae) |
chr16_+_1291240 | 12.04 |
ENST00000561736.1
|
TPSAB1
|
tryptase alpha/beta 1 |
chr17_-_42992856 | 12.04 |
ENST00000588316.1
ENST00000435360.2 ENST00000586793.1 ENST00000588735.1 ENST00000588037.1 ENST00000592320.1 ENST00000253408.5 |
GFAP
|
glial fibrillary acidic protein |
chr19_-_54784353 | 11.94 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr5_-_176057365 | 11.92 |
ENST00000310112.3
|
SNCB
|
synuclein, beta |
chr16_+_4784273 | 11.89 |
ENST00000299320.5
ENST00000586724.1 |
C16orf71
|
chromosome 16 open reading frame 71 |
chr12_+_66218212 | 11.88 |
ENST00000393578.3
ENST00000425208.2 ENST00000536545.1 ENST00000354636.3 |
HMGA2
|
high mobility group AT-hook 2 |
chr19_+_57742431 | 11.87 |
ENST00000302804.7
|
AURKC
|
aurora kinase C |
chr14_+_74111578 | 11.84 |
ENST00000554113.1
ENST00000555631.2 ENST00000553645.2 ENST00000311089.3 ENST00000555919.3 ENST00000554339.1 ENST00000554871.1 |
DNAL1
|
dynein, axonemal, light chain 1 |
chr9_+_124048864 | 11.75 |
ENST00000545652.1
|
GSN
|
gelsolin |
chr19_+_39897453 | 11.68 |
ENST00000597629.1
ENST00000248673.3 ENST00000594045.1 ENST00000594442.1 |
ZFP36
|
ZFP36 ring finger protein |
chr1_-_15850839 | 11.67 |
ENST00000348549.5
ENST00000546424.1 |
CASP9
|
caspase 9, apoptosis-related cysteine peptidase |
chr10_+_88728189 | 11.63 |
ENST00000416348.1
|
ADIRF
|
adipogenesis regulatory factor |
chr2_+_10184302 | 11.61 |
ENST00000440320.1
ENST00000535335.1 |
KLF11
|
Kruppel-like factor 11 |
chr2_+_68961905 | 11.61 |
ENST00000295381.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr2_-_99224915 | 11.60 |
ENST00000328709.3
ENST00000409997.1 |
COA5
|
cytochrome c oxidase assembly factor 5 |
chr2_-_71454185 | 11.58 |
ENST00000244221.8
|
PAIP2B
|
poly(A) binding protein interacting protein 2B |
chr19_-_47164386 | 11.56 |
ENST00000391916.2
ENST00000410105.2 |
DACT3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr14_-_60337684 | 11.55 |
ENST00000267484.5
|
RTN1
|
reticulon 1 |
chr22_-_18923655 | 11.54 |
ENST00000438924.1
ENST00000457083.1 ENST00000420436.1 ENST00000334029.2 ENST00000357068.6 |
PRODH
|
proline dehydrogenase (oxidase) 1 |
chr19_-_18391708 | 11.53 |
ENST00000600972.1
|
JUND
|
jun D proto-oncogene |
chr2_+_25016282 | 11.52 |
ENST00000260662.1
|
CENPO
|
centromere protein O |
chr10_+_134145614 | 11.49 |
ENST00000368615.3
ENST00000392638.2 ENST00000344079.5 ENST00000356571.4 ENST00000368614.3 |
LRRC27
|
leucine rich repeat containing 27 |
chr3_-_167813132 | 11.49 |
ENST00000309027.4
|
GOLIM4
|
golgi integral membrane protein 4 |
chr19_+_1067271 | 11.47 |
ENST00000536472.1
ENST00000590214.1 |
HMHA1
|
histocompatibility (minor) HA-1 |
chr19_-_14016877 | 11.47 |
ENST00000454313.1
ENST00000591586.1 ENST00000346736.2 |
C19orf57
|
chromosome 19 open reading frame 57 |
chr1_-_160681593 | 11.43 |
ENST00000368045.3
ENST00000368046.3 |
CD48
|
CD48 molecule |
chr10_-_21786179 | 11.41 |
ENST00000377113.5
|
CASC10
|
cancer susceptibility candidate 10 |
chr14_-_21567009 | 11.39 |
ENST00000556174.1
ENST00000554478.1 ENST00000553980.1 ENST00000421093.2 |
ZNF219
|
zinc finger protein 219 |
chr9_-_111929560 | 11.39 |
ENST00000561981.2
|
FRRS1L
|
ferric-chelate reductase 1-like |
chr1_-_213031418 | 11.39 |
ENST00000356684.3
ENST00000426161.1 ENST00000424044.1 |
FLVCR1-AS1
|
FLVCR1 antisense RNA 1 (head to head) |
chrX_-_47479246 | 11.31 |
ENST00000295987.7
ENST00000340666.4 |
SYN1
|
synapsin I |
chr22_+_23243156 | 11.28 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
chr7_+_30960915 | 11.28 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
chr8_+_141521386 | 11.27 |
ENST00000220913.5
ENST00000519533.1 |
CHRAC1
|
chromatin accessibility complex 1 |
chrX_-_17879356 | 11.26 |
ENST00000331511.1
ENST00000415486.3 ENST00000545871.1 ENST00000451717.1 |
RAI2
|
retinoic acid induced 2 |
chr1_+_22963158 | 11.25 |
ENST00000438241.1
|
C1QA
|
complement component 1, q subcomponent, A chain |
chr1_+_202830876 | 11.24 |
ENST00000456105.2
|
RP11-480I12.7
|
RP11-480I12.7 |
chr19_-_37019562 | 11.22 |
ENST00000523638.1
|
ZNF260
|
zinc finger protein 260 |
chr20_+_58508817 | 11.12 |
ENST00000358293.3
|
FAM217B
|
family with sequence similarity 217, member B |
chrX_+_56259316 | 11.08 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
chr9_-_93405352 | 11.05 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr11_-_113746277 | 11.05 |
ENST00000003302.4
ENST00000545540.1 |
USP28
|
ubiquitin specific peptidase 28 |
chrX_-_153881842 | 11.04 |
ENST00000369585.3
ENST00000247306.4 |
CTAG2
|
cancer/testis antigen 2 |
chr13_-_114898016 | 11.03 |
ENST00000542651.1
ENST00000334062.7 |
RASA3
|
RAS p21 protein activator 3 |
chr4_+_7045042 | 11.01 |
ENST00000310074.7
ENST00000512388.1 |
TADA2B
|
transcriptional adaptor 2B |
chr1_-_156217822 | 11.01 |
ENST00000368270.1
|
PAQR6
|
progestin and adipoQ receptor family member VI |
chr4_-_166034029 | 11.00 |
ENST00000306480.6
|
TMEM192
|
transmembrane protein 192 |
chr5_+_141303373 | 10.97 |
ENST00000432126.2
ENST00000194118.4 |
KIAA0141
|
KIAA0141 |
chr1_-_17445930 | 10.96 |
ENST00000375486.4
ENST00000375481.1 ENST00000444885.2 |
PADI2
|
peptidyl arginine deiminase, type II |
chr11_-_64510409 | 10.94 |
ENST00000394429.1
ENST00000394428.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr11_+_82612740 | 10.93 |
ENST00000524921.1
ENST00000528759.1 ENST00000525361.1 ENST00000430323.2 ENST00000533655.1 ENST00000532764.1 ENST00000532589.1 ENST00000525388.1 |
C11orf82
|
chromosome 11 open reading frame 82 |
chr16_+_23847339 | 10.85 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr9_+_87283430 | 10.85 |
ENST00000376214.1
ENST00000376213.1 |
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr11_-_64512803 | 10.85 |
ENST00000377489.1
ENST00000354024.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr16_-_30032610 | 10.82 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
chr11_+_119076745 | 10.82 |
ENST00000264033.4
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase |
chr15_+_31619013 | 10.77 |
ENST00000307145.3
|
KLF13
|
Kruppel-like factor 13 |
chr5_-_130970723 | 10.77 |
ENST00000308008.6
ENST00000296859.6 ENST00000507093.1 ENST00000510071.1 ENST00000509018.1 ENST00000307984.5 |
RAPGEF6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
chr6_-_46459099 | 10.75 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
chr20_-_58508702 | 10.73 |
ENST00000357552.3
ENST00000425931.1 |
SYCP2
|
synaptonemal complex protein 2 |
chr17_-_42402138 | 10.71 |
ENST00000592857.1
ENST00000586016.1 ENST00000590194.1 ENST00000377095.5 ENST00000588049.1 ENST00000586633.1 ENST00000537904.2 ENST00000585636.1 ENST00000585523.1 ENST00000225308.8 |
SLC25A39
|
solute carrier family 25, member 39 |
chr20_+_3801162 | 10.66 |
ENST00000379573.2
ENST00000379567.2 ENST00000455742.1 ENST00000246041.2 |
AP5S1
|
adaptor-related protein complex 5, sigma 1 subunit |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.5 | 49.6 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
14.1 | 42.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
13.7 | 13.7 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
13.3 | 79.8 | GO:1902847 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
9.2 | 45.8 | GO:0015670 | carbon dioxide transport(GO:0015670) |
9.1 | 36.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
8.5 | 25.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
7.8 | 39.0 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
7.3 | 21.8 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
7.1 | 7.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
7.0 | 21.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
6.9 | 41.7 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
6.8 | 20.4 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
6.7 | 13.5 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
6.5 | 6.5 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
6.5 | 64.6 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
6.4 | 25.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
6.4 | 6.4 | GO:0051604 | protein maturation(GO:0051604) |
6.3 | 31.6 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
6.1 | 18.4 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
6.0 | 24.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
5.9 | 17.6 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
5.8 | 29.0 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
5.8 | 17.4 | GO:1990502 | dense core granule maturation(GO:1990502) |
5.6 | 27.9 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
5.4 | 21.7 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
4.6 | 18.6 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
4.6 | 13.8 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
4.6 | 27.4 | GO:0005985 | sucrose metabolic process(GO:0005985) |
4.5 | 18.2 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
4.5 | 4.5 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
4.4 | 4.4 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
4.4 | 13.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
4.2 | 8.4 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
4.2 | 12.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
4.1 | 4.1 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
4.1 | 12.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
4.1 | 4.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
4.0 | 12.0 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
4.0 | 7.9 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
3.9 | 23.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
3.8 | 15.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
3.8 | 38.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
3.7 | 11.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
3.7 | 22.0 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
3.7 | 11.0 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
3.6 | 14.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
3.6 | 14.5 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
3.6 | 14.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
3.6 | 21.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
3.6 | 21.3 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
3.5 | 7.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
3.5 | 62.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
3.5 | 3.5 | GO:0070560 | protein secretion by platelet(GO:0070560) |
3.4 | 10.3 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
3.4 | 6.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.4 | 10.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
3.4 | 10.1 | GO:0071529 | cementum mineralization(GO:0071529) |
3.3 | 13.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
3.3 | 20.0 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
3.3 | 13.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
3.3 | 13.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
3.3 | 3.3 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
3.3 | 16.5 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
3.3 | 16.4 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
3.3 | 58.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
3.3 | 9.8 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
3.3 | 9.8 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
3.2 | 6.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
3.2 | 13.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
3.2 | 9.7 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
3.2 | 9.6 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
3.1 | 25.1 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
3.1 | 6.3 | GO:1903413 | cellular response to bile acid(GO:1903413) |
3.1 | 9.4 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
3.1 | 9.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
3.1 | 21.5 | GO:0045007 | depurination(GO:0045007) |
3.1 | 18.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
3.0 | 12.2 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
3.0 | 15.1 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
3.0 | 3.0 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
3.0 | 3.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
2.9 | 8.8 | GO:0007497 | posterior midgut development(GO:0007497) |
2.9 | 26.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
2.9 | 5.8 | GO:1901859 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
2.9 | 8.6 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
2.9 | 8.6 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.9 | 17.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
2.8 | 5.7 | GO:0033590 | response to cobalamin(GO:0033590) |
2.8 | 28.2 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.8 | 8.5 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
2.8 | 8.4 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
2.8 | 2.8 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
2.8 | 2.8 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
2.8 | 5.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
2.8 | 16.5 | GO:0051414 | response to cortisol(GO:0051414) |
2.8 | 11.0 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
2.7 | 30.2 | GO:0033227 | dsRNA transport(GO:0033227) |
2.7 | 11.0 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
2.7 | 8.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
2.7 | 5.5 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
2.7 | 8.2 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
2.7 | 2.7 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
2.7 | 8.1 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
2.7 | 18.9 | GO:2001023 | regulation of response to drug(GO:2001023) |
2.7 | 10.8 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
2.7 | 5.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
2.7 | 8.0 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
2.7 | 2.7 | GO:0043379 | memory T cell differentiation(GO:0043379) |
2.7 | 2.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
2.6 | 15.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
2.6 | 2.6 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
2.6 | 5.1 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
2.6 | 28.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
2.6 | 5.1 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
2.6 | 10.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
2.6 | 2.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
2.5 | 12.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
2.5 | 2.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
2.5 | 12.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
2.5 | 15.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
2.5 | 5.0 | GO:0009648 | photoperiodism(GO:0009648) entrainment of circadian clock(GO:0009649) entrainment of circadian clock by photoperiod(GO:0043153) |
2.5 | 5.0 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
2.5 | 19.7 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.5 | 7.4 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
2.4 | 26.9 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
2.4 | 9.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.4 | 14.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
2.4 | 7.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
2.4 | 7.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
2.4 | 9.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
2.4 | 28.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.4 | 9.4 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
2.3 | 23.4 | GO:0048102 | autophagic cell death(GO:0048102) |
2.3 | 157.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
2.3 | 4.7 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
2.3 | 16.3 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
2.3 | 16.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
2.3 | 7.0 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
2.3 | 16.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
2.3 | 9.2 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
2.3 | 6.9 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
2.3 | 11.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
2.3 | 13.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
2.3 | 4.5 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
2.3 | 6.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
2.3 | 4.5 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
2.2 | 9.0 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
2.2 | 4.5 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
2.2 | 13.5 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
2.2 | 33.5 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.2 | 2.2 | GO:0051885 | positive regulation of anagen(GO:0051885) |
2.2 | 4.4 | GO:0060374 | mast cell differentiation(GO:0060374) |
2.2 | 2.2 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
2.2 | 15.4 | GO:0006772 | thiamine metabolic process(GO:0006772) |
2.2 | 32.5 | GO:0015671 | oxygen transport(GO:0015671) |
2.2 | 6.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.2 | 10.8 | GO:0035063 | nuclear speck organization(GO:0035063) |
2.2 | 10.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
2.1 | 6.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
2.1 | 6.4 | GO:0001207 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
2.1 | 6.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
2.1 | 16.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
2.1 | 14.7 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
2.1 | 8.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.1 | 12.5 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
2.1 | 6.2 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
2.1 | 8.3 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
2.1 | 8.3 | GO:1902075 | cellular response to salt(GO:1902075) |
2.1 | 14.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
2.1 | 6.2 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
2.1 | 4.1 | GO:1904048 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) regulation of spontaneous neurotransmitter secretion(GO:1904048) |
2.0 | 2.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
2.0 | 6.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
2.0 | 10.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
2.0 | 10.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.0 | 9.9 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
2.0 | 9.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.0 | 21.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.0 | 9.9 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
2.0 | 5.9 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
2.0 | 7.8 | GO:1905073 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
2.0 | 3.9 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.9 | 5.8 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
1.9 | 9.7 | GO:1901907 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
1.9 | 7.7 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
1.9 | 5.8 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
1.9 | 3.9 | GO:0042116 | macrophage activation(GO:0042116) |
1.9 | 3.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.9 | 5.7 | GO:0008355 | olfactory learning(GO:0008355) |
1.9 | 5.7 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
1.9 | 5.6 | GO:0070781 | response to biotin(GO:0070781) |
1.9 | 9.4 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
1.9 | 15.0 | GO:0015705 | iodide transport(GO:0015705) |
1.9 | 13.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
1.9 | 5.6 | GO:0007602 | phototransduction(GO:0007602) |
1.8 | 3.7 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
1.8 | 22.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
1.8 | 5.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.8 | 5.5 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
1.8 | 16.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.8 | 7.2 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
1.8 | 10.8 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.8 | 9.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.8 | 157.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.8 | 9.0 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
1.8 | 10.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.8 | 10.7 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.8 | 5.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.8 | 1.8 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
1.8 | 1.8 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
1.8 | 5.3 | GO:1901727 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
1.8 | 3.5 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
1.8 | 21.2 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
1.8 | 22.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
1.7 | 5.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.7 | 10.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
1.7 | 7.0 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
1.7 | 1.7 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.7 | 6.9 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.7 | 5.2 | GO:0003095 | pressure natriuresis(GO:0003095) |
1.7 | 3.5 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
1.7 | 10.3 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
1.7 | 12.0 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.7 | 5.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
1.7 | 1.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.7 | 6.8 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.7 | 13.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.7 | 5.1 | GO:1902809 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.7 | 5.1 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
1.7 | 6.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.7 | 10.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
1.7 | 3.4 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
1.7 | 20.2 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
1.7 | 1.7 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.7 | 5.0 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
1.7 | 3.3 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
1.7 | 5.0 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
1.6 | 1.6 | GO:0007521 | muscle cell fate determination(GO:0007521) |
1.6 | 13.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.6 | 8.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.6 | 4.9 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.6 | 16.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.6 | 6.6 | GO:0010165 | response to X-ray(GO:0010165) |
1.6 | 3.3 | GO:0032607 | interferon-alpha production(GO:0032607) |
1.6 | 4.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.6 | 6.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
1.6 | 11.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.6 | 11.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
1.6 | 8.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.6 | 6.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.6 | 4.8 | GO:0061461 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
1.6 | 3.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.6 | 3.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.6 | 6.3 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
1.6 | 6.3 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
1.6 | 3.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
1.6 | 11.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.6 | 1.6 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
1.6 | 18.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.6 | 6.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.5 | 10.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.5 | 60.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.5 | 7.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.5 | 1.5 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
1.5 | 16.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.5 | 9.2 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
1.5 | 6.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
1.5 | 4.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.5 | 18.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
1.5 | 3.0 | GO:0044782 | cilium organization(GO:0044782) |
1.5 | 4.5 | GO:0032571 | response to vitamin K(GO:0032571) |
1.5 | 6.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
1.5 | 6.0 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
1.5 | 3.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.5 | 16.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.5 | 22.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.5 | 7.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.5 | 5.9 | GO:0009409 | response to cold(GO:0009409) |
1.5 | 8.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.5 | 5.9 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.5 | 8.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
1.5 | 8.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.5 | 2.9 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.5 | 7.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.5 | 11.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.5 | 8.7 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
1.5 | 36.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.5 | 2.9 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.4 | 5.8 | GO:0044026 | DNA hypermethylation(GO:0044026) |
1.4 | 4.3 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
1.4 | 4.3 | GO:1900369 | transcription, RNA-templated(GO:0001172) regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) positive regulation of protein localization to nucleolus(GO:1904751) |
1.4 | 7.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.4 | 12.9 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
1.4 | 4.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
1.4 | 11.4 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.4 | 2.8 | GO:0009299 | mRNA transcription(GO:0009299) |
1.4 | 2.8 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.4 | 4.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.4 | 4.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
1.4 | 23.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.4 | 4.2 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
1.4 | 7.0 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
1.4 | 2.8 | GO:0070256 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
1.4 | 12.4 | GO:0032341 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) |
1.4 | 5.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
1.4 | 4.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.4 | 5.5 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.4 | 1.4 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
1.4 | 4.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
1.4 | 4.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.4 | 8.2 | GO:0018343 | protein farnesylation(GO:0018343) |
1.4 | 4.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
1.4 | 12.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
1.4 | 13.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
1.4 | 4.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
1.3 | 5.4 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
1.3 | 21.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
1.3 | 5.4 | GO:0032252 | secretory granule localization(GO:0032252) |
1.3 | 2.7 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.3 | 6.7 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.3 | 16.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
1.3 | 8.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.3 | 8.0 | GO:0070255 | regulation of mucus secretion(GO:0070255) positive regulation of mucus secretion(GO:0070257) |
1.3 | 5.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.3 | 13.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.3 | 4.0 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
1.3 | 9.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
1.3 | 4.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.3 | 3.9 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.3 | 3.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
1.3 | 3.9 | GO:0060974 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
1.3 | 95.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
1.3 | 5.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
1.3 | 5.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.3 | 3.9 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
1.3 | 10.4 | GO:0014848 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
1.3 | 6.5 | GO:0003431 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) |
1.3 | 5.1 | GO:0034699 | response to luteinizing hormone(GO:0034699) cellular response to luteinizing hormone stimulus(GO:0071373) |
1.3 | 2.6 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
1.3 | 5.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
1.3 | 5.1 | GO:0019054 | modulation by virus of host morphology or physiology(GO:0019048) modulation by virus of host process(GO:0019054) |
1.3 | 14.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
1.3 | 3.8 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.3 | 26.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
1.2 | 6.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.2 | 5.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.2 | 17.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.2 | 11.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.2 | 8.6 | GO:0015824 | proline transport(GO:0015824) |
1.2 | 9.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.2 | 14.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
1.2 | 3.6 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
1.2 | 2.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
1.2 | 8.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.2 | 6.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.2 | 9.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.2 | 2.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
1.2 | 1.2 | GO:0071848 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
1.2 | 4.8 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
1.2 | 7.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
1.2 | 1.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
1.2 | 7.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
1.2 | 4.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
1.2 | 1.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.2 | 7.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.2 | 4.7 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
1.2 | 16.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.2 | 30.6 | GO:0001825 | blastocyst formation(GO:0001825) |
1.2 | 4.7 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
1.2 | 8.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.2 | 4.7 | GO:1905176 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
1.2 | 8.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
1.2 | 3.5 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.2 | 5.8 | GO:0080009 | mRNA methylation(GO:0080009) |
1.2 | 4.6 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
1.2 | 3.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.1 | 3.4 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
1.1 | 3.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
1.1 | 12.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.1 | 4.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.1 | 4.6 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
1.1 | 46.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.1 | 10.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.1 | 8.0 | GO:0042426 | choline catabolic process(GO:0042426) |
1.1 | 3.4 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
1.1 | 2.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.1 | 6.8 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.1 | 2.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.1 | 2.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.1 | 2.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.1 | 1.1 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
1.1 | 1.1 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
1.1 | 7.8 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.1 | 4.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.1 | 5.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.1 | 2.2 | GO:0007418 | ventral midline development(GO:0007418) cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.1 | 3.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) |
1.1 | 7.7 | GO:1903232 | melanosome assembly(GO:1903232) |
1.1 | 4.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.1 | 3.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.1 | 2.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
1.1 | 2.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.1 | 3.3 | GO:0002118 | aggressive behavior(GO:0002118) |
1.1 | 29.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
1.1 | 30.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.1 | 1.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.1 | 3.3 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
1.1 | 14.1 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
1.1 | 5.4 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
1.1 | 5.4 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
1.1 | 6.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.1 | 3.2 | GO:2000824 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) negative regulation of androgen receptor activity(GO:2000824) |
1.1 | 27.7 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
1.1 | 8.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.1 | 3.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
1.1 | 21.2 | GO:0045730 | respiratory burst(GO:0045730) |
1.1 | 7.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.1 | 6.3 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
1.1 | 5.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.0 | 5.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.0 | 2.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.0 | 8.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.0 | 7.3 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
1.0 | 3.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
1.0 | 4.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.0 | 5.1 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
1.0 | 2.0 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
1.0 | 3.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.0 | 17.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.0 | 4.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.0 | 3.0 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
1.0 | 8.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.0 | 7.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
1.0 | 3.0 | GO:0034371 | chylomicron remodeling(GO:0034371) |
1.0 | 4.0 | GO:0006272 | leading strand elongation(GO:0006272) |
1.0 | 2.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.0 | 3.0 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
1.0 | 24.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
1.0 | 4.0 | GO:0043307 | eosinophil activation(GO:0043307) |
1.0 | 3.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
1.0 | 4.9 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
1.0 | 3.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.0 | 5.9 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.0 | 2.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.0 | 3.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.0 | 9.7 | GO:0032364 | oxygen homeostasis(GO:0032364) |
1.0 | 9.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.0 | 3.9 | GO:0003335 | corneocyte development(GO:0003335) |
1.0 | 1.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.0 | 9.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.0 | 21.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.9 | 6.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.9 | 3.8 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.9 | 5.7 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.9 | 3.8 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.9 | 2.8 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.9 | 5.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.9 | 18.7 | GO:0097503 | sialylation(GO:0097503) |
0.9 | 2.8 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.9 | 14.9 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.9 | 0.9 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.9 | 2.8 | GO:0071423 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.9 | 3.7 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.9 | 2.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.9 | 5.5 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.9 | 8.2 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.9 | 5.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.9 | 0.9 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.9 | 1.8 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.9 | 3.6 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.9 | 13.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.9 | 1.8 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.9 | 2.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.9 | 4.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.9 | 3.6 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.9 | 6.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.9 | 2.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.9 | 5.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.9 | 8.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.9 | 2.7 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.9 | 11.5 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.9 | 3.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.9 | 3.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.9 | 9.6 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.9 | 6.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.9 | 13.9 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.9 | 8.6 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.9 | 3.4 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.9 | 6.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.9 | 5.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 9.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.9 | 4.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.9 | 5.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.9 | 6.0 | GO:0007135 | meiosis II(GO:0007135) |
0.9 | 10.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.9 | 1.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.9 | 11.9 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.9 | 22.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.8 | 9.3 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.8 | 4.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.8 | 8.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.8 | 6.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.8 | 6.7 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.8 | 16.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.8 | 1.7 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.8 | 5.9 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.8 | 2.5 | GO:0042048 | olfactory behavior(GO:0042048) |
0.8 | 5.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.8 | 17.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.8 | 4.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.8 | 2.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.8 | 3.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.8 | 2.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.8 | 3.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.8 | 2.5 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.8 | 3.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.8 | 6.6 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.8 | 3.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.8 | 2.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.8 | 3.3 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.8 | 2.4 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.8 | 21.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.8 | 2.4 | GO:2000672 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
0.8 | 10.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.8 | 2.4 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.8 | 2.4 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.8 | 2.4 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.8 | 1.6 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.8 | 7.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.8 | 6.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.8 | 3.2 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.8 | 15.8 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.8 | 9.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.8 | 5.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.8 | 11.0 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.8 | 2.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.8 | 2.4 | GO:2000096 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.8 | 2.3 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.8 | 5.5 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.8 | 4.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.8 | 4.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.8 | 1.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.8 | 10.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.8 | 3.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.8 | 16.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.8 | 3.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.8 | 1.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.8 | 6.9 | GO:0014029 | neural crest formation(GO:0014029) |
0.8 | 1.5 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.8 | 3.0 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.8 | 34.7 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.8 | 9.0 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.7 | 3.7 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.7 | 5.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.7 | 7.4 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.7 | 16.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.7 | 3.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.7 | 1.5 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.7 | 3.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.7 | 18.5 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.7 | 11.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.7 | 5.2 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.7 | 9.5 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.7 | 13.2 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.7 | 8.1 | GO:0006473 | protein acetylation(GO:0006473) |
0.7 | 2.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 1.5 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.7 | 5.8 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.7 | 2.9 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.7 | 1.5 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.7 | 4.4 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
0.7 | 2.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.7 | 2.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.7 | 0.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 1.4 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.7 | 9.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.7 | 3.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.7 | 8.6 | GO:0021794 | thalamus development(GO:0021794) |
0.7 | 5.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.7 | 13.5 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.7 | 3.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.7 | 2.8 | GO:0019086 | late viral transcription(GO:0019086) |
0.7 | 6.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.7 | 6.3 | GO:0021756 | striatum development(GO:0021756) |
0.7 | 6.3 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.7 | 6.3 | GO:0015747 | urate transport(GO:0015747) |
0.7 | 2.8 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.7 | 2.8 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
0.7 | 2.1 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.7 | 2.1 | GO:0007538 | primary sex determination(GO:0007538) |
0.7 | 0.7 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.7 | 1.4 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.7 | 2.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.7 | 1.4 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.7 | 2.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.7 | 2.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.7 | 2.7 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct morphogenesis(GO:0072180) |
0.7 | 5.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.7 | 2.7 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.7 | 3.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.7 | 0.7 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.7 | 10.8 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.7 | 9.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.7 | 3.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.7 | 2.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.7 | 2.0 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.7 | 6.6 | GO:0086070 | SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.7 | 9.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.7 | 7.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.7 | 4.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.7 | 2.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.7 | 3.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.7 | 0.7 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.7 | 3.3 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 2.0 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.6 | 3.2 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.6 | 1.9 | GO:0010193 | response to ozone(GO:0010193) |
0.6 | 18.1 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.6 | 4.5 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.6 | 0.6 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.6 | 2.6 | GO:0072658 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.6 | 1.9 | GO:1900060 | glucosylceramide biosynthetic process(GO:0006679) negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.6 | 1.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.6 | 1.9 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 3.8 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
0.6 | 11.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.6 | 0.6 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.6 | 2.5 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.6 | 0.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 9.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.6 | 1.9 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.6 | 1.9 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.6 | 6.2 | GO:0060022 | hard palate development(GO:0060022) |
0.6 | 6.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.6 | 3.1 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.6 | 1.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.6 | 1.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.6 | 10.0 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.6 | 10.6 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.6 | 2.5 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.6 | 1.8 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.6 | 11.7 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.6 | 1.2 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.6 | 1.8 | GO:0035607 | vacuolar phosphate transport(GO:0007037) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.6 | 1.2 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.6 | 29.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.6 | 1.8 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.6 | 1.2 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
0.6 | 8.5 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.6 | 10.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.6 | 0.6 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.6 | 1.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.6 | 7.2 | GO:0097369 | sodium ion import(GO:0097369) |
0.6 | 10.8 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.6 | 5.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.6 | 3.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.6 | 4.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.6 | 7.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.6 | 1.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.6 | 1.8 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.6 | 4.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.6 | 11.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.6 | 12.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.6 | 2.9 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.6 | 2.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.6 | 1.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.6 | 1.7 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) primary lung bud formation(GO:0060431) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.6 | 2.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.6 | 4.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.6 | 5.7 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.6 | 5.2 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.6 | 7.5 | GO:0042755 | eating behavior(GO:0042755) |
0.6 | 1.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.6 | 2.9 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.6 | 1.7 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.6 | 3.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 13.7 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.6 | 2.3 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.6 | 1.7 | GO:0051710 | cytolysis by symbiont of host cells(GO:0001897) regulation of cytolysis in other organism(GO:0051710) cytolysis in other organism involved in symbiotic interaction(GO:0051801) |
0.6 | 2.3 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.6 | 0.6 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.6 | 9.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.6 | 5.0 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.6 | 2.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 36.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.6 | 2.2 | GO:0060534 | negative regulation of granulocyte differentiation(GO:0030853) Sertoli cell fate commitment(GO:0060010) trachea cartilage development(GO:0060534) |
0.6 | 3.3 | GO:1903147 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.6 | 0.6 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.6 | 2.2 | GO:0045425 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.6 | 2.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.5 | 21.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.5 | 5.4 | GO:0090193 | positive regulation of glomerulus development(GO:0090193) |
0.5 | 6.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.5 | 4.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.5 | 7.0 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.5 | 0.5 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.5 | 1.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.5 | 14.9 | GO:0071625 | vocalization behavior(GO:0071625) |
0.5 | 2.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.5 | 2.1 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.5 | 2.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.5 | 3.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.5 | 14.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.5 | 6.8 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.5 | 4.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.5 | 2.6 | GO:0072189 | ureter maturation(GO:0035799) ureter development(GO:0072189) |
0.5 | 6.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.5 | 3.6 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.5 | 2.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.5 | 1.0 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.5 | 1.0 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.5 | 2.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 29.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.5 | 3.5 | GO:0046618 | drug export(GO:0046618) |
0.5 | 2.0 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.5 | 6.0 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.5 | 3.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.5 | 1.5 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.5 | 5.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 1.5 | GO:0060290 | transdifferentiation(GO:0060290) |
0.5 | 1.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.5 | 2.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.5 | 1.5 | GO:0097680 | DNA ligation involved in DNA recombination(GO:0051102) double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.5 | 6.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.5 | 2.0 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.5 | 0.5 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.5 | 1.0 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.5 | 2.9 | GO:0030539 | male genitalia development(GO:0030539) |
0.5 | 6.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.5 | 9.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.5 | 1.4 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.5 | 1.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.5 | 3.8 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.5 | 3.8 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.5 | 15.5 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.5 | 2.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.5 | 3.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.5 | 2.3 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.5 | 2.7 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.5 | 2.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 2.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.5 | 2.3 | GO:0048243 | norepinephrine secretion(GO:0048243) |
0.4 | 1.8 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.4 | 1.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.4 | 1.8 | GO:1904588 | thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.4 | 1.8 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.4 | 4.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 2.6 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.4 | 1.7 | GO:0035624 | receptor transactivation(GO:0035624) |
0.4 | 4.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.4 | 1.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.4 | 6.0 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.4 | 0.9 | GO:0043132 | NAD transport(GO:0043132) |
0.4 | 6.8 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.4 | 3.4 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.4 | 2.9 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.4 | 1.7 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.4 | 2.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 2.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 5.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 0.8 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.4 | 1.6 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 0.8 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.4 | 1.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 7.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.4 | 2.0 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.4 | 2.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 3.6 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.4 | 2.4 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.4 | 2.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.4 | 14.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.4 | 5.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.4 | 1.2 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.4 | 0.4 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 2.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 1.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.4 | 2.8 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.4 | 4.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 5.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.4 | 4.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 2.3 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.4 | 2.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 0.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 1.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.4 | 2.3 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.4 | 1.1 | GO:1901731 | positive regulation of platelet activation(GO:0010572) positive regulation of platelet aggregation(GO:1901731) regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.4 | 1.5 | GO:0030168 | platelet activation(GO:0030168) |
0.4 | 2.2 | GO:0010665 | regulation of striated muscle cell apoptotic process(GO:0010662) regulation of cardiac muscle cell apoptotic process(GO:0010665) |
0.4 | 1.9 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.4 | 2.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 3.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.4 | 1.1 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.4 | 1.1 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.4 | 8.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.4 | 2.5 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.4 | 13.5 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.4 | 2.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.4 | 2.9 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.4 | 1.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.4 | 5.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.4 | 2.9 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.4 | 5.7 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.4 | 18.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 37.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 1.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.4 | 8.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 4.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.3 | 3.4 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.3 | 2.8 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.3 | 13.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 2.1 | GO:0019184 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 1.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) potassium ion export across plasma membrane(GO:0097623) |
0.3 | 1.4 | GO:0006757 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
0.3 | 1.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 1.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.3 | 1.3 | GO:1904238 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.3 | 2.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.3 | 6.6 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.3 | 4.5 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.3 | 4.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.6 | GO:0051608 | histamine transport(GO:0051608) |
0.3 | 1.9 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.3 | 1.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.3 | 0.6 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.3 | 4.0 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.3 | 1.5 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.3 | 5.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.3 | 3.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 1.5 | GO:0015791 | polyol transport(GO:0015791) |
0.3 | 0.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.3 | 0.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 1.8 | GO:0000050 | urea cycle(GO:0000050) |
0.3 | 2.6 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.3 | 1.5 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.3 | 1.7 | GO:0055123 | digestive system development(GO:0055123) |
0.3 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) positive regulation of gastrulation(GO:2000543) |
0.3 | 4.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.3 | 0.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.3 | 2.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 2.8 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.3 | 0.8 | GO:0010873 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) positive regulation of cholesterol esterification(GO:0010873) |
0.3 | 1.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 0.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 0.6 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 1.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 6.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 2.2 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.3 | 0.8 | GO:1903845 | negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.3 | 2.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 1.4 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.3 | 8.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.3 | 1.1 | GO:0048477 | oogenesis(GO:0048477) |
0.3 | 1.3 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.3 | 0.8 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.3 | 1.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 3.1 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.3 | 2.6 | GO:0006833 | water transport(GO:0006833) |
0.3 | 1.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 0.5 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
0.3 | 2.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 0.5 | GO:1904892 | regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
0.3 | 2.6 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.3 | 5.3 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 0.8 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
0.2 | 0.7 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.2 | 1.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 2.5 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 3.0 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.2 | 2.0 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.2 | 6.4 | GO:0030317 | sperm motility(GO:0030317) |
0.2 | 2.0 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.2 | 0.5 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.2 | 1.0 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.2 | 2.4 | GO:0007628 | adult walking behavior(GO:0007628) |
0.2 | 2.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 6.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.2 | 2.6 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) |
0.2 | 13.3 | GO:0030282 | bone mineralization(GO:0030282) |
0.2 | 15.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.9 | GO:0006068 | ethanol metabolic process(GO:0006067) ethanol catabolic process(GO:0006068) |
0.2 | 3.2 | GO:0042552 | myelination(GO:0042552) |
0.2 | 3.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 3.9 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.2 | 1.4 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.2 | 3.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 8.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 3.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 1.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.2 | 2.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 1.3 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 1.1 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.2 | 1.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 1.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.6 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.2 | 2.4 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.2 | 1.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 6.0 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 6.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 3.6 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 1.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 1.2 | GO:0060394 | negative regulation of SMAD protein complex assembly(GO:0010991) negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.6 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 3.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.2 | 1.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 1.9 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.6 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.2 | 1.7 | GO:0010224 | response to UV-B(GO:0010224) |
0.2 | 1.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.2 | 1.1 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.2 | 0.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 0.7 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 2.5 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.2 | 3.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.2 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.2 | 0.5 | GO:1901978 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) |
0.2 | 1.4 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.2 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.9 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.2 | 1.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.2 | 0.5 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.2 | 1.2 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 1.2 | GO:0071715 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.2 | 1.5 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.2 | 2.0 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 2.3 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.2 | 0.3 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.2 | 2.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 5.1 | GO:0061337 | cardiac conduction(GO:0061337) |
0.2 | 3.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.3 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 3.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 12.2 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 1.2 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 3.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.4 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 2.3 | GO:0036508 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) |
0.1 | 0.1 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 3.5 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.1 | GO:0060896 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
0.1 | 1.9 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 2.7 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 1.3 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 4.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.3 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 1.6 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.1 | 1.2 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 2.2 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.4 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
0.1 | 1.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 1.4 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 2.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 1.9 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 2.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 2.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 2.6 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 1.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.8 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 1.4 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 0.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 1.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 3.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 1.6 | GO:0050433 | regulation of catecholamine secretion(GO:0050433) |
0.1 | 1.0 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.1 | 0.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 3.4 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 1.2 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 1.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 1.0 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 4.4 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.1 | 0.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 1.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.9 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 1.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.4 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
0.1 | 0.7 | GO:0051272 | positive regulation of cellular component movement(GO:0051272) |
0.1 | 0.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 1.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 2.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 1.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.1 | 3.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.8 | GO:0000423 | macromitophagy(GO:0000423) |
0.1 | 0.8 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 0.4 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 1.5 | GO:0021983 | pituitary gland development(GO:0021983) |
0.1 | 0.2 | GO:0043545 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 3.0 | GO:0021782 | glial cell development(GO:0021782) |
0.1 | 1.4 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.1 | GO:1904429 | regulation of t-circle formation(GO:1904429) positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 1.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 1.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.7 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.4 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.8 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 5.4 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 16.2 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.2 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.4 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 2.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.9 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 4.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 1.1 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.2 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0046503 | glycerophospholipid catabolic process(GO:0046475) glycerolipid catabolic process(GO:0046503) |
0.0 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.0 | 0.4 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.0 | 0.4 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 50.6 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
8.6 | 25.8 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
8.0 | 40.2 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
7.7 | 30.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
6.5 | 104.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
6.1 | 18.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
5.7 | 40.1 | GO:0033269 | internode region of axon(GO:0033269) |
4.5 | 95.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
4.5 | 18.1 | GO:0043293 | apoptosome(GO:0043293) |
4.4 | 13.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
4.3 | 21.7 | GO:0005602 | complement component C1 complex(GO:0005602) |
3.8 | 11.3 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
3.7 | 44.7 | GO:0043203 | axon hillock(GO:0043203) |
3.5 | 13.8 | GO:1990745 | EARP complex(GO:1990745) |
3.4 | 10.1 | GO:0072534 | perineuronal net(GO:0072534) |
3.4 | 10.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
3.3 | 13.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
3.3 | 13.3 | GO:0097224 | sperm connecting piece(GO:0097224) |
3.3 | 13.1 | GO:0031417 | NatC complex(GO:0031417) |
3.3 | 152.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
3.2 | 9.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
3.1 | 9.4 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
3.1 | 21.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
3.0 | 60.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
2.8 | 11.0 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
2.8 | 22.0 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
2.7 | 8.2 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
2.6 | 13.1 | GO:0001652 | granular component(GO:0001652) |
2.5 | 7.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
2.5 | 7.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
2.5 | 7.4 | GO:0036398 | TCR signalosome(GO:0036398) |
2.5 | 19.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
2.4 | 19.6 | GO:0042583 | chromaffin granule(GO:0042583) |
2.4 | 12.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
2.3 | 23.4 | GO:0071953 | elastic fiber(GO:0071953) |
2.3 | 18.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
2.3 | 9.0 | GO:0032010 | phagolysosome(GO:0032010) |
2.2 | 6.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
2.1 | 10.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
2.1 | 4.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.0 | 16.2 | GO:0036157 | outer dynein arm(GO:0036157) |
2.0 | 18.1 | GO:0070652 | HAUS complex(GO:0070652) |
2.0 | 15.9 | GO:0098845 | postsynaptic endosome(GO:0098845) |
2.0 | 5.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.9 | 13.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.9 | 5.8 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
1.9 | 1.9 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
1.9 | 24.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.9 | 9.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.8 | 7.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
1.8 | 16.1 | GO:0033391 | chromatoid body(GO:0033391) |
1.8 | 17.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.8 | 44.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.7 | 24.3 | GO:0033270 | paranode region of axon(GO:0033270) |
1.7 | 13.5 | GO:0035976 | AP1 complex(GO:0035976) |
1.7 | 5.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
1.7 | 8.3 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
1.7 | 14.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.6 | 45.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
1.6 | 9.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.6 | 6.5 | GO:0045160 | myosin I complex(GO:0045160) |
1.6 | 11.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.6 | 3.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
1.6 | 17.3 | GO:0005614 | interstitial matrix(GO:0005614) |
1.6 | 28.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.6 | 3.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
1.5 | 4.6 | GO:0098536 | deuterosome(GO:0098536) |
1.5 | 1.5 | GO:0030673 | axolemma(GO:0030673) |
1.5 | 6.1 | GO:0045179 | apical cortex(GO:0045179) |
1.5 | 30.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.5 | 6.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.5 | 6.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
1.5 | 3.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
1.4 | 17.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
1.4 | 22.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.4 | 1.4 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
1.4 | 4.3 | GO:0031251 | PAN complex(GO:0031251) |
1.4 | 4.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
1.4 | 1.4 | GO:0043291 | RAVE complex(GO:0043291) |
1.4 | 5.6 | GO:0005921 | gap junction(GO:0005921) |
1.4 | 8.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.3 | 8.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
1.3 | 6.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.2 | 7.5 | GO:1990037 | Lewy body core(GO:1990037) |
1.2 | 7.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.2 | 14.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.2 | 6.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.2 | 17.3 | GO:0035102 | PRC1 complex(GO:0035102) |
1.2 | 18.1 | GO:0000124 | SAGA complex(GO:0000124) |
1.2 | 3.6 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
1.2 | 31.8 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
1.2 | 12.8 | GO:0043194 | axon initial segment(GO:0043194) |
1.2 | 18.5 | GO:0097386 | glial cell projection(GO:0097386) |
1.1 | 15.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.1 | 3.4 | GO:0043159 | acrosomal matrix(GO:0043159) |
1.1 | 2.2 | GO:0043083 | synaptic cleft(GO:0043083) |
1.1 | 3.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.1 | 7.6 | GO:0001520 | outer dense fiber(GO:0001520) |
1.1 | 3.2 | GO:0005883 | neurofilament(GO:0005883) |
1.1 | 4.3 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
1.1 | 6.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.1 | 11.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.1 | 2.1 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
1.0 | 3.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
1.0 | 4.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
1.0 | 77.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.0 | 5.0 | GO:0071439 | clathrin complex(GO:0071439) |
1.0 | 8.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.0 | 23.2 | GO:0034451 | centriolar satellite(GO:0034451) |
1.0 | 8.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.9 | 11.3 | GO:0036038 | MKS complex(GO:0036038) |
0.9 | 41.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.9 | 6.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.9 | 4.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.9 | 3.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.9 | 1.8 | GO:0033010 | paranodal junction(GO:0033010) |
0.9 | 1.8 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.9 | 3.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.9 | 3.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.9 | 16.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.9 | 12.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.8 | 1.7 | GO:0000791 | euchromatin(GO:0000791) |
0.8 | 2.5 | GO:0060187 | cell pole(GO:0060187) |
0.8 | 12.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.8 | 5.1 | GO:0033063 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.8 | 1.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.8 | 6.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.8 | 0.8 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.8 | 9.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 12.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.8 | 83.5 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.8 | 4.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.8 | 4.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.8 | 3.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.8 | 3.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.8 | 7.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.8 | 1.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.8 | 3.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.8 | 10.0 | GO:0042599 | lamellar body(GO:0042599) |
0.8 | 10.7 | GO:0043218 | compact myelin(GO:0043218) |
0.8 | 1.5 | GO:0044305 | calyx of Held(GO:0044305) |
0.8 | 3.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.8 | 1.5 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.8 | 3.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 27.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.7 | 4.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.7 | 3.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.7 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.7 | 2.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 0.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.7 | 3.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.7 | 2.8 | GO:0031905 | early endosome lumen(GO:0031905) |
0.7 | 2.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.7 | 55.7 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.7 | 2.7 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.7 | 46.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 2.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.7 | 4.0 | GO:0097433 | dense body(GO:0097433) |
0.7 | 98.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 2.6 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.7 | 6.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.6 | 16.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 41.2 | GO:0005902 | microvillus(GO:0005902) |
0.6 | 9.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.6 | 6.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 6.2 | GO:0071437 | invadopodium(GO:0071437) |
0.6 | 5.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.6 | 3.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.6 | 82.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.6 | 4.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 26.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.6 | 1.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 63.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.6 | 18.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.6 | 4.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.6 | 2.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.6 | 8.4 | GO:0030478 | actin cap(GO:0030478) |
0.6 | 3.3 | GO:0097227 | sperm annulus(GO:0097227) |
0.6 | 3.3 | GO:0032009 | early phagosome(GO:0032009) |
0.5 | 5.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.5 | 10.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 2.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.5 | 17.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 15.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.5 | 1.0 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.5 | 5.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.5 | 3.0 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.5 | 10.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.5 | 2.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 2.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 2.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.5 | 9.0 | GO:0032420 | stereocilium(GO:0032420) |
0.5 | 1.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 63.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.5 | 4.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.5 | 3.6 | GO:0043196 | varicosity(GO:0043196) |
0.4 | 6.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 1.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.4 | 2.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 3.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 2.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 4.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.4 | 10.2 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.4 | 4.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 2.0 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 2.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 4.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 1.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 3.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 31.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.4 | 2.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.4 | 3.5 | GO:0031906 | late endosome lumen(GO:0031906) |
0.4 | 3.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 1.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 4.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 10.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 20.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 3.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 52.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 5.2 | GO:0097546 | ciliary base(GO:0097546) |
0.4 | 14.1 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.4 | 5.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 1.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.4 | 12.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.4 | 3.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 2.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 6.4 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 2.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 2.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 2.1 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 4.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 6.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 83.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.3 | 1.7 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.3 | 1.0 | GO:0097447 | dendritic tree(GO:0097447) |
0.3 | 2.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 2.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.0 | GO:0034657 | GID complex(GO:0034657) |
0.3 | 22.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 8.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.3 | 4.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 0.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.3 | 23.5 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 13.7 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 6.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 2.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 4.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 2.0 | GO:0097361 | CIA complex(GO:0097361) |
0.3 | 2.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 13.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 9.1 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 7.3 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.2 | 21.3 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 4.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 2.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 2.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 1.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 1.1 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.2 | 1.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 12.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 3.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 1.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 5.5 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 1.6 | GO:0016013 | syntrophin complex(GO:0016013) |
0.2 | 1.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 0.8 | GO:0032044 | DSIF complex(GO:0032044) |
0.2 | 11.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 2.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 6.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 5.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.2 | 12.5 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 2.0 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 3.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 1.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 518.2 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 7.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 1.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 6.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 100.8 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 4.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.4 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.6 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 5.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 1.9 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.3 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.0 | 0.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.7 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.6 | 58.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
9.1 | 36.3 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
8.3 | 50.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
7.7 | 53.8 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
7.4 | 89.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
6.4 | 25.7 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
6.1 | 18.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
6.0 | 18.0 | GO:0034584 | piRNA binding(GO:0034584) |
5.9 | 17.6 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
5.6 | 27.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
5.4 | 21.5 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
5.0 | 19.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
4.7 | 18.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
4.6 | 4.6 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
4.5 | 81.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
4.5 | 90.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
4.4 | 13.3 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
4.1 | 12.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
4.1 | 16.4 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
4.0 | 16.0 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
3.8 | 11.5 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
3.8 | 15.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
3.8 | 22.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
3.8 | 11.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
3.8 | 11.3 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
3.8 | 15.0 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
3.6 | 14.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
3.6 | 21.5 | GO:0008430 | selenium binding(GO:0008430) |
3.6 | 32.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.5 | 21.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
3.5 | 7.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
3.5 | 14.0 | GO:0004803 | transposase activity(GO:0004803) |
3.5 | 20.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
3.4 | 17.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
3.4 | 3.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
3.3 | 183.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
3.3 | 16.5 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
3.2 | 13.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
3.2 | 6.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
3.1 | 9.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
3.1 | 31.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
3.1 | 9.4 | GO:0035473 | lipase binding(GO:0035473) |
3.0 | 3.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
3.0 | 8.9 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
2.9 | 14.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.9 | 8.7 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
2.9 | 8.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
2.8 | 8.5 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
2.8 | 8.5 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
2.8 | 8.4 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
2.8 | 38.9 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
2.8 | 8.3 | GO:0004040 | amidase activity(GO:0004040) |
2.8 | 13.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
2.8 | 2.8 | GO:0019209 | kinase activator activity(GO:0019209) |
2.8 | 11.0 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
2.7 | 21.5 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
2.6 | 7.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.6 | 12.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.5 | 32.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
2.5 | 17.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
2.5 | 5.0 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.5 | 7.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.5 | 7.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
2.5 | 7.4 | GO:0004962 | endothelin receptor activity(GO:0004962) |
2.5 | 7.4 | GO:0004802 | transketolase activity(GO:0004802) |
2.5 | 19.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
2.4 | 4.9 | GO:0070052 | collagen V binding(GO:0070052) |
2.4 | 14.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.4 | 7.3 | GO:0004103 | choline kinase activity(GO:0004103) |
2.4 | 7.3 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
2.4 | 14.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
2.4 | 9.6 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
2.3 | 7.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
2.3 | 4.7 | GO:0070905 | serine binding(GO:0070905) |
2.3 | 7.0 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
2.3 | 6.9 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
2.3 | 9.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
2.2 | 6.7 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
2.2 | 15.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.2 | 11.0 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
2.2 | 13.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
2.2 | 10.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
2.2 | 8.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
2.2 | 10.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
2.2 | 21.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
2.2 | 15.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.2 | 19.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.2 | 8.6 | GO:0097001 | ceramide binding(GO:0097001) |
2.2 | 8.6 | GO:0017040 | ceramidase activity(GO:0017040) |
2.2 | 8.6 | GO:0051380 | norepinephrine binding(GO:0051380) |
2.1 | 12.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.1 | 52.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
2.1 | 4.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
2.1 | 8.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
2.1 | 6.3 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
2.1 | 6.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.0 | 12.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
2.0 | 28.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.0 | 30.3 | GO:0015250 | water channel activity(GO:0015250) |
2.0 | 10.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
2.0 | 13.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.0 | 25.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
2.0 | 9.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
2.0 | 5.9 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
2.0 | 9.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
1.9 | 9.7 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
1.9 | 5.8 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
1.9 | 9.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.9 | 100.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
1.8 | 12.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.8 | 14.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.8 | 5.5 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
1.8 | 16.3 | GO:0043426 | MRF binding(GO:0043426) |
1.8 | 21.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.8 | 7.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.8 | 12.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.8 | 7.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.8 | 3.5 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
1.8 | 44.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.7 | 5.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.7 | 5.2 | GO:0051425 | PTB domain binding(GO:0051425) |
1.7 | 19.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.7 | 5.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.7 | 5.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.7 | 5.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.7 | 3.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.7 | 11.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.7 | 5.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.7 | 5.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
1.7 | 5.0 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
1.7 | 13.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.7 | 5.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.7 | 5.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.7 | 5.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
1.6 | 9.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.6 | 11.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
1.6 | 4.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.6 | 1.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.5 | 4.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
1.5 | 1.5 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
1.5 | 4.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.5 | 4.5 | GO:0017129 | triglyceride binding(GO:0017129) |
1.5 | 7.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.5 | 5.8 | GO:0001855 | complement component C4b binding(GO:0001855) |
1.5 | 5.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.4 | 11.5 | GO:0030172 | troponin C binding(GO:0030172) |
1.4 | 4.3 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
1.4 | 4.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
1.4 | 4.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.4 | 8.6 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
1.4 | 245.2 | GO:0003823 | antigen binding(GO:0003823) |
1.4 | 5.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.4 | 8.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.4 | 56.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.4 | 6.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
1.4 | 2.7 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
1.4 | 14.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.3 | 5.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
1.3 | 13.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.3 | 4.0 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
1.3 | 5.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
1.3 | 15.4 | GO:0045159 | myosin II binding(GO:0045159) |
1.3 | 2.6 | GO:0016405 | CoA-ligase activity(GO:0016405) |
1.3 | 10.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
1.3 | 35.7 | GO:0005521 | lamin binding(GO:0005521) |
1.3 | 6.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.3 | 6.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
1.3 | 17.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
1.2 | 32.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.2 | 9.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
1.2 | 3.7 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.2 | 16.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.2 | 6.2 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
1.2 | 4.9 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
1.2 | 14.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.2 | 4.8 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
1.2 | 6.0 | GO:0004359 | glutaminase activity(GO:0004359) |
1.2 | 7.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.2 | 60.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.2 | 8.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.2 | 7.0 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
1.2 | 4.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.2 | 2.3 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
1.2 | 15.1 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
1.2 | 28.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.1 | 3.4 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
1.1 | 12.6 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.1 | 5.7 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
1.1 | 3.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.1 | 6.8 | GO:0004522 | ribonuclease A activity(GO:0004522) |
1.1 | 7.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.1 | 4.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.1 | 6.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.1 | 2.2 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
1.1 | 3.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.1 | 5.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
1.1 | 3.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.1 | 3.3 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
1.1 | 6.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.1 | 7.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.1 | 8.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.1 | 15.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
1.1 | 3.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.1 | 33.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.1 | 4.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
1.1 | 6.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.1 | 11.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.1 | 10.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.0 | 6.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.0 | 3.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.0 | 15.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.0 | 2.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.0 | 6.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
1.0 | 9.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.0 | 10.2 | GO:0015643 | toxic substance binding(GO:0015643) |
1.0 | 20.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.0 | 8.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.0 | 10.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.0 | 3.0 | GO:0032090 | Pyrin domain binding(GO:0032090) |
1.0 | 3.0 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
1.0 | 4.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.0 | 16.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
1.0 | 3.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
1.0 | 3.9 | GO:0061714 | folic acid receptor activity(GO:0061714) |
1.0 | 5.9 | GO:0004882 | androgen receptor activity(GO:0004882) |
1.0 | 2.9 | GO:0004797 | thymidine kinase activity(GO:0004797) |
1.0 | 6.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.0 | 6.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.0 | 15.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.0 | 13.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.0 | 25.9 | GO:0070840 | dynein complex binding(GO:0070840) |
1.0 | 6.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.9 | 10.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.9 | 14.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.9 | 2.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.9 | 7.5 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.9 | 3.7 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.9 | 14.9 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.9 | 43.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.9 | 2.8 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.9 | 33.1 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.9 | 8.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.9 | 2.8 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.9 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.9 | 9.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.9 | 6.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.9 | 3.6 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.9 | 3.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.9 | 2.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.9 | 3.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.9 | 2.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.9 | 1.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.9 | 0.9 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.9 | 3.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.9 | 6.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.9 | 3.5 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.9 | 22.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.9 | 21.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.9 | 8.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.9 | 6.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.9 | 21.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.9 | 12.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.9 | 14.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.8 | 5.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.8 | 2.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.8 | 1.7 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.8 | 3.4 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.8 | 14.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.8 | 6.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.8 | 3.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.8 | 11.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.8 | 12.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.8 | 4.0 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.8 | 15.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.8 | 0.8 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.8 | 8.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.8 | 1.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.8 | 4.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.8 | 13.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.8 | 23.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.8 | 3.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.8 | 2.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.8 | 5.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.8 | 15.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.8 | 17.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.8 | 4.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.8 | 10.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.8 | 3.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 8.4 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.8 | 12.9 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.8 | 1.5 | GO:0043559 | insulin binding(GO:0043559) |
0.7 | 39.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.7 | 42.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.7 | 1.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.7 | 5.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 11.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.7 | 2.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.7 | 15.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.7 | 11.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.7 | 3.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.7 | 3.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.7 | 4.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.7 | 2.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.7 | 8.5 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.7 | 12.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.7 | 12.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.7 | 2.8 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.7 | 2.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.7 | 2.8 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 2.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) purinergic receptor activity(GO:0035586) |
0.7 | 2.1 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.7 | 2.7 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.7 | 3.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.7 | 4.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.7 | 4.0 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.7 | 5.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.7 | 4.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.7 | 3.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.7 | 7.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.7 | 2.6 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.7 | 10.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.7 | 3.3 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.7 | 18.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 3.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.6 | 10.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 4.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.6 | 2.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 4.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.6 | 13.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.6 | 9.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.6 | 0.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 3.1 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.6 | 134.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.6 | 66.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 1.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.6 | 3.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.6 | 2.4 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.6 | 1.8 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.6 | 6.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 15.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 2.4 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.6 | 1.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription coactivator binding(GO:0001225) |
0.6 | 3.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.6 | 10.1 | GO:0070513 | death domain binding(GO:0070513) |
0.6 | 12.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.6 | 10.0 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.6 | 2.9 | GO:0086077 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.6 | 13.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.6 | 7.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.6 | 2.9 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.6 | 1.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 1.7 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.6 | 2.8 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.6 | 1.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) apolipoprotein A-I receptor binding(GO:0034191) |
0.6 | 5.6 | GO:0015925 | galactosidase activity(GO:0015925) |
0.5 | 3.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 8.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.5 | 11.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.5 | 3.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.5 | 0.5 | GO:0032357 | Y-form DNA binding(GO:0000403) heteroduplex DNA loop binding(GO:0000404) double-strand/single-strand DNA junction binding(GO:0000406) DNA insertion or deletion binding(GO:0032135) guanine/thymine mispair binding(GO:0032137) single base insertion or deletion binding(GO:0032138) dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) dinucleotide repeat insertion binding(GO:0032181) oxidized purine DNA binding(GO:0032357) |
0.5 | 2.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.5 | 2.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 7.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 3.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.5 | 11.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 3.2 | GO:0045569 | TRAIL binding(GO:0045569) |
0.5 | 2.1 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.5 | 20.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 48.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.5 | 4.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.5 | 0.5 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.5 | 9.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.5 | 1.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.5 | 3.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 3.0 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.5 | 4.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.5 | 1.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.5 | 7.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.5 | 14.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.5 | 10.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 4.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 1.0 | GO:0031545 | peptidyl-proline dioxygenase activity(GO:0031543) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 1.5 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.5 | 3.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 1.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.5 | 1.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.5 | 1.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 3.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 6.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 1.4 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.5 | 8.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.5 | 4.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 3.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.5 | 10.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.5 | 2.3 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.5 | 7.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.5 | 17.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.5 | 7.3 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.5 | 2.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.5 | 1.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.5 | 3.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.5 | 5.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 1.8 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.4 | 1.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 0.9 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 11.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 1.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 1.7 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.4 | 5.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.4 | 1.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 1.7 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.4 | 37.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 2.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 2.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.4 | 4.2 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.4 | 0.8 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.4 | 11.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 3.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 1.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 2.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 6.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.4 | 3.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 9.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 6.8 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.4 | 8.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 9.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 7.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 2.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 1.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 3.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 2.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 1.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 1.5 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.4 | 1.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 1.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 1.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.4 | 10.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.4 | 1.9 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.4 | 4.8 | GO:0001093 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) TFIIB-class transcription factor binding(GO:0001093) |
0.4 | 2.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.4 | 8.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 16.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.4 | 1.1 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.4 | 2.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 1.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 1.4 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.4 | 2.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 2.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 6.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 2.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 4.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 11.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 0.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 1.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 2.0 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 1.3 | GO:0047708 | biotinidase activity(GO:0047708) |
0.3 | 2.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 2.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 8.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 9.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 2.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 3.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.3 | 7.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 3.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 43.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 3.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 3.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.3 | 9.0 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.3 | 6.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.3 | 108.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.3 | 4.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 0.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 7.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.3 | 10.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 2.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 2.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 2.9 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 2.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 2.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 0.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 0.8 | GO:0031711 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
0.3 | 1.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 2.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.3 | 0.8 | GO:0034041 | lipid-transporting ATPase activity(GO:0034040) sterol-transporting ATPase activity(GO:0034041) |
0.3 | 1.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 0.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 1.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.3 | 1.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.3 | 3.4 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.5 | GO:0039552 | RIG-I binding(GO:0039552) |
0.3 | 0.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 2.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.3 | 4.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 7.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 1.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 1.7 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 9.6 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 11.7 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.2 | 5.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 2.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 20.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 7.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 2.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 1.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 2.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.0 | GO:0022821 | calcium, potassium:sodium antiporter activity(GO:0008273) potassium ion antiporter activity(GO:0022821) |
0.2 | 1.0 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 1.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 2.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 3.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 4.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.8 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.2 | 1.5 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.2 | 1.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 1.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 1.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 4.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 1.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 2.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 5.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.5 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
0.2 | 3.4 | GO:0019905 | syntaxin binding(GO:0019905) |
0.2 | 2.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 7.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 2.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 1.0 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 0.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 1.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.6 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.1 | 3.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.6 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 1.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 1.7 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 3.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 11.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 3.8 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 3.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 8.1 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 2.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 2.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 1.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 21.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 1.4 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 3.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 3.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 3.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.9 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 1.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.1 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 1.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 2.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 5.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 69.3 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 2.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 1.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.4 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.1 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.1 | 0.7 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.1 | 3.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.8 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 1.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.7 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.0 | 0.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.9 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 2.3 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.8 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.1 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 110.4 | PID RAS PATHWAY | Regulation of Ras family activation |
1.9 | 7.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.7 | 1.7 | PID MYC PATHWAY | C-MYC pathway |
1.6 | 3.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.6 | 60.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.6 | 3.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.6 | 10.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.4 | 56.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.2 | 29.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.1 | 27.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.1 | 18.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
1.1 | 19.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.0 | 12.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.0 | 12.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.0 | 126.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.9 | 14.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.9 | 27.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.9 | 35.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.8 | 25.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.8 | 3.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 17.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.8 | 11.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 12.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.7 | 39.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.7 | 6.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.7 | 10.6 | ST ADRENERGIC | Adrenergic Pathway |
0.7 | 4.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 6.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 13.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.6 | 4.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.6 | 164.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.6 | 43.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.6 | 8.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.6 | 10.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.6 | 12.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.6 | 16.5 | PID EPO PATHWAY | EPO signaling pathway |
0.6 | 4.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 15.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 26.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 2.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.6 | 23.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.6 | 13.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.6 | 28.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.6 | 30.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 17.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 17.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.5 | 3.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 17.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 22.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 5.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.5 | 3.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.5 | 4.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.5 | 2.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 9.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.5 | 6.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 13.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.4 | 74.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 7.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.4 | 7.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 15.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 4.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 21.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 5.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 6.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 4.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 1.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 4.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 8.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 3.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 7.6 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 2.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 47.0 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.2 | 3.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 3.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 2.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 12.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 1.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 6.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 4.6 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
3.9 | 82.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
3.5 | 80.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
3.2 | 6.5 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
3.2 | 6.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
3.0 | 30.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.9 | 40.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
2.7 | 125.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.3 | 9.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.1 | 16.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.8 | 3.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
1.7 | 29.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.7 | 5.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
1.7 | 141.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.7 | 30.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.7 | 8.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.6 | 17.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.5 | 4.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.5 | 45.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.4 | 17.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.4 | 36.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.3 | 28.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.3 | 32.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.3 | 66.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.3 | 23.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.3 | 18.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.2 | 6.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.1 | 13.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.1 | 25.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.1 | 29.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.1 | 21.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.0 | 24.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.0 | 37.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
1.0 | 15.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
1.0 | 20.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.0 | 15.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.9 | 2.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.9 | 15.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.9 | 3.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.9 | 22.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.9 | 43.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.9 | 80.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.9 | 4.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.9 | 24.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.8 | 34.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.8 | 12.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.8 | 30.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.8 | 15.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.8 | 37.4 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.7 | 18.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 23.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 13.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.7 | 22.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.7 | 8.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 8.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.7 | 15.7 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.6 | 4.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.6 | 5.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.6 | 3.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.6 | 11.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.6 | 6.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 8.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.6 | 4.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 57.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.6 | 11.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.6 | 25.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.6 | 2.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.6 | 8.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.6 | 9.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.6 | 55.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.6 | 6.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.6 | 12.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.6 | 19.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 10.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 6.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 5.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 7.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 9.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 7.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 9.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 5.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 9.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 12.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.5 | 2.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.5 | 2.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 3.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 5.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.4 | 78.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.4 | 4.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 32.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.4 | 3.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.4 | 5.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 70.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 8.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 0.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 8.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 147.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.4 | 6.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 4.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 7.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 11.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 2.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.3 | 8.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 8.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 18.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 2.0 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.3 | 9.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 4.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.3 | 2.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 6.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 1.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 3.1 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.3 | 7.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 11.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.2 | 3.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 25.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 4.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 2.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 3.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 2.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 4.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 2.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.4 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
0.1 | 1.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 2.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 7.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 4.2 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.1 | 3.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 3.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |